Status:
COMPLETED
Mechanism of Aphakic and Pseudophakic Glaucoma in Pediatric Patients
Lead Sponsor:
Carmel Medical Center
Conditions:
Congenital Cataract
Aphakic or Pseudophakic Glaucoma
Eligibility:
All Genders
Up to 18 years
Brief Summary
In cell cultures, lens epithelial cells and trabecular meshwork cells will be exposed to aqueous humor from pediatric eyes undergoing cataract removal surgery. Cytokine analysis of candidate factors w...
Detailed Description
Aqueous from the anterior chamber will be withdrawn before surgery. Then the lens capsule will be opened (capsulorhexis) and removed. The lens material will be removed. All 3 components will be sent t...
Eligibility Criteria
Inclusion
- children with congenital cataract and are going to do removal surgery
- children with aphakic or pseudophakic glaucoma and are going to do glaucoma surgery
- both of parents are able to sign the INFORMED CONSENT FORM
Exclusion
- patients with other eye diseases apart from congenital cataract(in children with congenital cataract) and aphakic or pseudophakic glaucoma (in children with aphakic or pseudophakic glaucoma)
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01136473
Start Date
July 1 2011
End Date
September 1 2014
Last Update
February 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carmel Medical Center
Haifa, Israel